Global In Vitro Diagnostics Market Analysis and Forecasts to 2015


November 25, 2009
467 Pages - SKU: GBDT2508694
License type:
Table of Contents Search inside this report Related Reports Detailed Contents
1 Table Of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Executive Summary
4 Definitions of Markets Covered in This Report
4.1 In Vitro Diagnostics
4.2 Blood Test Reagents
4.3 Clinical Chemistry Test Reagents
4.4 Genetic Test Reagents
4.5 Immunochemistry Test Reagents
4.6 Infectious Immunology Test Reagents
4.7 Instruments
4.8 Microbiology Test Reagents
4.9 Self Testing
5 Global In Vitro Diagnostics
5.1 In Vitro Diagnostics, Global, Overall Revenue ($m), 2000-
5.2 In Vitro Diagnostics Market Dynamic
5.3 In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-
5.4 In Vitro Diagnostics, Global, Competitive Landscape
6 In Vitro Diagnostics Cross Country Comparison
6.1 In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2000-
7 In Vitro Diagnostics In US
7.1 In Vitro Diagnostics, US, Overall Revenue ($m), 2000-
7.2 In Vitro Diagnostics, US, Cross-Category Analysis, 2000-
7.3 In Vitro Diagnostics, US, Distribution Share (2007-2008)
7.4 In Vitro Diagnostics, US, Company Share (2007-2008)
8 In Vitro Diagnostics In Japan
8.1 In Vitro Diagnostics, Japan, Overall Revenue ($m), 2000-
8.2 In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-
8.3 In Vitro Diagnostics, Japan, Distribution Share (2007-2008)
8.4 In Vitro Diagnostics, Japan, Company Share (2007-2008)
9 In Vitro Diagnostics In Germany
9.1 In Vitro Diagnostics, Germany, Overall Revenue ($m), 2000-
9.2 In Vitro Diagnostics, Germany, Cross-Category Analysis, 2000-
9.3 In Vitro Diagnostics, Germany, Distribution Share (2007-2008)
9.4 In Vitro Diagnostics, Germany, Company Share (2007-2008)
10 In Vitro Diagnostics In Italy
10.1 In Vitro Diagnostics, Italy, Overall Revenue ($m), 2000-
10.2 In Vitro Diagnostics, Italy, Cross-Category Analysis, 2000-
10.3 In Vitro Diagnostics, Italy, Distribution Share (2007-2008)
10.4 In Vitro Diagnostics, Italy, Company Share (2007-2008)
11 In Vitro Diagnostics In France
11.1 In Vitro Diagnostics, France, Overall Revenue ($m), 2000-
11.2 In Vitro Diagnostics, France, Cross-Category Analysis, 2000-
11.3 In Vitro Diagnostics, France, Distribution Share (2007-2008)
11.4 In Vitro Diagnostics, France, Company Share (2007-2008)
12 In Vitro Diagnostics In China
12.1 In Vitro Diagnostics, China, Overall Revenue ($m), 2000-
12.2 In Vitro Diagnostics, China, Cross-Category Analysis, 2000-
12.3 In Vitro Diagnostics, China, Distribution Share (2007-2008)
12.4 In Vitro Diagnostics, China, Company Share (2007-2008)
13 In Vitro Diagnostics In Spain
13.1 In Vitro Diagnostics, Spain, Overall Revenue ($m), 2000-
13.2 In Vitro Diagnostics, Spain, Cross-Category Analysis, 2000-
13.3 In Vitro Diagnostics, Spain, Distribution Share (2007-2008)
13.4 In Vitro Diagnostics, Spain, Company Share (2007-2008)
14 In Vitro Diagnostics In UK
14.1 In Vitro Diagnostics, UK, Overall Revenue ($m), 2000-
14.2 In Vitro Diagnostics, UK, Cross-Category Analysis, 2000-
14.3 In Vitro Diagnostics, UK, Distribution Share (2007-2008)
14.4 In Vitro Diagnostics, UK, Company Share (2007-2008)
15 In Vitro Diagnostics In Brazil
15.1 In Vitro Diagnostics, Brazil, Overall Revenue ($m), 2000-
15.2 In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2000-
15.3 In Vitro Diagnostics, Brazil, Distribution Share (2007-2008)
15.4 In Vitro Diagnostics, Brazil, Company Share (2007-2008)
16 In Vitro Diagnostics In Canada
16.1 In Vitro Diagnostics, Canada, Overall Revenue ($m), 2000-
16.2 In Vitro Diagnostics, Canada, Cross-Category Analysis, 2000-
16.3 In Vitro Diagnostics, Canada, Distribution Share (2007-2008)
16.4 In Vitro Diagnostics, Canada, Company Share (2007-2008)
17 In Vitro Diagnostics In India
17.1 In Vitro Diagnostics, India, Overall Revenue ($m), 2000-
17.2 In Vitro Diagnostics, India, Cross-Category Analysis, 2000-
17.3 In Vitro Diagnostics, India, Distribution Share (2007-2008)
17.4 In Vitro Diagnostics, India, Company Share (2007-2008)
18 In Vitro Diagnostics In Australia
18.1 In Vitro Diagnostics, Australia, Overall Revenue ($m), 2000-
18.2 In Vitro Diagnostics, Australia, Cross-Category Analysis, 2000-
18.3 In Vitro Diagnostics, Australia, Distribution Share (2007-2008)
18.4 In Vitro Diagnostics, Australia, Company Share (2007-2008)
19 Overview of Key Companies in In Vitro Diagnostics Market
19.1 F. Hoffmann-La Roche Ltd.
19.2 Siemens Healthcare
19.3 Abbott Laboratories
19.4 Beckman Coulter, Inc.
19.5 Ortho-Clinical Diagnostics Inc.
19.6 bioMerieux S.A.
20 Financial Deals Landscape
20.1 Financial Deal Analysis Deal Type
20.2 Financial Deal Analysis - Deal Value and Volume
20.3 Merger
20.4 Acquisition
20.5 Partnerships
21 Recent Developments
21.1 Strategy And Business Planning
21.2 Legal and Regulatory
21.3 Government and Public Interest
21.4 Other Significant Developments
22 Appendix
22.1 GlobalData Research Methodology
22.2 Secondary Research
22.3 Primary Research
22.4 Models
22.5 Forecasts
22.6 Expert Panel Validation
22.7 Currency Conversion
22.8 Contact Us
22.9 Disclaimer
1.1 List of Tables
Table 1: In Vitro Diagnostics, Global, Overall Revenue ($m), Historic, 2000-2008
Table 2: In Vitro Diagnostics, Global, Overall Revenue ($m), Forecast, 2008-2015
Table 3: In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015
Table 4: In Vitro Diagnostics, Global, Company share by Revenue ($m), 2007-2008
Table 5: In Vitro Diagnostics, Market Attractiveness Analysis, By Category, 2008 - 2015
Table 6: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2000-2015
Table 7: In Vitro Diagnostics, US, Overall Revenue ($m), Historic, 2000-2008
Table 8: In Vitro Diagnostics, US, Overall Revenue ($m), Forecast, 2008-2015
Table 9: In Vitro Diagnostics, US, Cross-Category Analysis, 2000-2015
Table 10: Clinical Chemistry, US, Distribution Share by Revenue ($m), 2007-2008
Table 11: Genetic Testing, US, Distribution Share by Revenue ($m), 2007-2008
Table 12: Haematology, US, Distribution Share by Revenue ($m), 2007-2008
Table 13: Histology And Cytology, US, Distribution Share by Revenue ($m), 2007-2008
Table 14: Immuno Chemistry, US, Distribution Share by Revenue ($m), 2007-2008
Table 15: Infectious Immunology, US, Distribution Share by Revenue ($m), 2007-2008
Table 16: Microbiology Culture, US, Distribution Share by Revenue ($m), 2007-2008
Table 17: In Vitro Diagnostics, US, Company Share by Revenue ($m), 2008-2008
Table 18: Clinical Chemistry, US, Company Share by Revenue ($m), 2007-2008
Table 19: Genetic Testing, US, Company Share by Revenue ($m), 2007-2008
Table 20: Haematology, US, Company Share by Revenue ($m), 2007-2008
Table 21: Histology And Cytology, US, Company Share by Revenue ($m), 2007-2008
Table 22: Immuno Chemistry, US, Company Share by Revenue ($m), 2007-2008
Table 23: Infectious Immunology, US, Company Share by Revenue ($m), 2007-2008
Table 24: Microbiology Culture, US, Company Share by Revenue ($m), 2007-2008
Table 25: In Vitro Diagnostics, Japan, Overall Revenue ($m), Historic, 2000-2008
Table 26: In Vitro Diagnostics, Japan, Overall Revenue ($m), Forecast, 2008-2015
Table 27: In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-2015
Table 28: Clinical Chemistry, Japan, Distribution Share by Revenue ($m), 2007-2008
Table 29: Genetic Testing, Japan, Distribution Share by Revenue ($m), 2007-2008
Table 30: Haematology, Japan, Distribution Share by Revenue ($m), 2007-2008
Table 31: Histology And Cytology, Japan, Distribution Share by Revenue ($m), 2007-2008
Table 32: Immuno Chemistry, Japan, Distribution Share by Revenue ($m), 2007-2008
Table 33: Infectious Immunology, Japan, Distribution Share by Revenue ($m), 2007-2008
Table 34: Microbiology Culture, Japan, Distribution Share by Revenue ($m), 2007-2008
Table 35: In Vitro Diagnostics, Japan, Company Share by Revenue ($m), 2008-2008
Table 36: Clinical Chemistry, Japan, Company Share by Revenue ($m), 2007-2008
Table 37: Genetic Testing, Japan, Company Share by Revenue ($m), 2007-2008
Table 38: Haematology, Japan, Company Share by Revenue ($m), 2007-2008
Table 39: Histology And Cytology, Japan, Company Share by Revenue ($m), 2007-2008
Table 40: Immuno Chemistry, Japan, Company Share by Revenue ($m), 2007-2008
Table 41: Infectious Immunology, Japan, Company Share by Revenue ($m), 2007-2008
Table 42: Microbiology Culture, Japan, Company Share by Revenue ($m), 2007-2008
Table 43: In Vitro Diagnostics, Germany, Overall Revenue ($m), Historic, 2000-2008
Table 44: In Vitro Diagnostics, Germany, Overall Revenue ($m), Forecast, 2008-2015
Table 45: In Vitro Diagnostics, Germany, Cross-Category Analysis, 2000-2015
Table 46: Clinical Chemistry, Germany, Distribution Share by Revenue ($m), 2007-2008
Table 47: Genetic Testing, Germany, Distribution Share by Revenue ($m), 2007-2008
Table 48: Haematology, Germany, Distribution Share by Revenue ($m), 2007-2008
Table 49: Histology And Cytology, Germany, Distribution Share by Revenue ($m), 2007-2008
Table 50: Immuno Chemistry, Germany, Distribution Share by Revenue ($m), 2007-2008
Table 51: Infectious Immunology, Germany, Distribution Share by Revenue ($m), 2007-2008
Table 52: Microbiology Culture, Germany, Distribution Share by Revenue ($m), 2007-2008
Table 53: In Vitro Diagnostics, Germany, Company Share by Revenue ($m), 2008-2008
Table 54: Clinical Chemistry, Germany, Company Share by Revenue ($m), 2007-2008
Table 55: Genetic Testing, Germany, Company Share by Revenue ($m), 2007-2008
Table 56: Haematology, Germany, Company Share by Revenue ($m), 2007-2008
Table 57: Histology And Cytology, Germany, Company Share by Revenue ($m), 2007-2008
Table 58: Immuno Chemistry, Germany, Company Share by Revenue ($m), 2007-2008
Table 59: Infectious Immunology, Germany, Company Share by Revenue ($m), 2007-2008
Table 60: Microbiology Culture, Germany, Company Share by Revenue ($m), 2007-2008
Table 61: In Vitro Diagnostics, Italy, Overall Revenue ($m), Historic, 2000-2008
Table 62: In Vitro Diagnostics, Italy, Overall Revenue ($m), Forecast, 2008-2015
Table 63: In Vitro Diagnostics, Italy, Cross-Category Analysis, 2000-2015
Table 64: Clinical Chemistry, Italy, Distribution Share by Revenue ($m), 2007-2008
Table 65: Genetic Testing, Italy, Distribution Share by Revenue ($m), 2007-2008
Table 66: Haematology, Italy, Distribution Share by Revenue ($m), 2007-2008
Table 67: Histology And Cytology, Italy, Distribution Share by Revenue ($m), 2007-2008
Table 68: Immuno Chemistry, Italy, Distribution Share by Revenue ($m), 2007-2008
Table 69: Infectious Immunology, Italy, Distribution Share by Revenue ($m), 2007-2008
Table 70: Microbiology Culture, Italy, Distribution Share by Revenue ($m), 2007-2008
Table 71: In Vitro Diagnostics, Italy, Company Share by Revenue ($m), 2008-2008
Table 72: Clinical Chemistry, Italy, Company Share by Revenue ($m), 2007-2008
Table 73: Genetic Testing, Italy, Company Share by Revenue ($m), 2007-2008
Table 74: Haematology, Italy, Company Share by Revenue ($m), 2007-2008
Table 75: Histology And Cytology, Italy, Company Share by Revenue ($m), 2007-2008
Table 76: Immuno Chemistry, Italy, Company Share by Revenue ($m), 2007-2008
Table 77: Infectious Immunology, Italy, Company Share by Revenue ($m), 2007-2008
Table 78: Microbiology Culture, Italy, Company Share by Revenue ($m), 2007-2008
Table 79: In Vitro Diagnostics, France, Overall Revenue ($m), Historic, 2000-2008
Table 80: In Vitro Diagnostics, France, Overall Revenue ($m), Forecast, 2008-2015
Table 81: In Vitro Diagnostics, France, Cross-Category Analysis, 2000-2015
Table 82: Clinical Chemistry, France, Distribution Share by Revenue ($m), 2007-2008
Table 83: Genetic Testing, France, Distribution Share by Revenue ($m), 2007-2008
Table 84: Haematology, France, Distribution Share by Revenue ($m), 2007-2008
Table 85: Histology And Cytology, France, Distribution Share by Revenue ($m), 2007-2008
Table 86: Immuno Chemistry, France, Distribution Share by Revenue ($m), 2007-2008
Table 87: Infectious Immunology, France, Distribution Share by Revenue ($m), 2007-2008
Table 88: Microbiology Culture, France, Distribution Share by Revenue ($m), 2007-2008
Table 89: In Vitro Diagnostics, France, Company Share by Revenue ($m), 2008-2008
Table 90: Clinical Chemistry, France, Company Share by Revenue ($m), 2007-2008
Table 91: Genetic Testing, France, Company Share by Revenue ($m), 2007-2008
Table 92: Haematology, France, Company Share by Revenue ($m), 2007-2008
Table 93: Histology And Cytology, France, Company Share by Revenue ($m), 2007-2008
Table 94: Immuno Chemistry, France, Company Share by Revenue ($m), 2007-2008
Table 95: Infectious Immunology, France, Company Share by Revenue ($m), 2007-2008
Table 96: Microbiology Culture, France, Company Share by Revenue ($m), 2007-2008
Table 97: In Vitro Diagnostics, China, Overall Revenue ($m), Historic, 2000-2008
Table 98: In Vitro Diagnostics, China, Overall Revenue ($m), Forecast, 2008-2015
Table 99: In Vitro Diagnostics, China, Cross-Category Analysis, 2000-2015
Table 100: Clinical Chemistry, China, Distribution Share by Revenue ($m), 2007-2008
Table 101: Genetic Testing, China, Distribution Share by Revenue ($m), 2007-2008
Table 102: Haematology, China, Distribution Share by Revenue ($m), 2007-2008
Table 103: Histology And Cytology, China, Distribution Share by Revenue ($m), 2007-2008
Table 104: Immuno Chemistry, China, Distribution Share by Revenue ($m), 2007-2008
Table 105: Infectious Immunology, China, Distribution Share by Revenue ($m), 2007-2008
Table 106: Microbiology Culture, China, Distribution Share by Revenue ($m), 2007-2008
Table 107: In Vitro Diagnostics, China, Company Share by Revenue ($m), 2008-2008
Table 108: Clinical Chemistry, China, Company Share by Revenue ($m), 2007-2008
Table 109: Genetic Testing, China, Company Share by Revenue ($m), 2007-2008
Table 110: Haematology, China, Company Share by Revenue ($m), 2007-2008
Table 111: Histology And Cytology, China, Company Share by Revenue ($m), 2007-2008
Table 112: Immuno Chemistry, China, Company Share by Revenue ($m), 2007-2008
Table 113: Infectious Immunology, China, Company Share by Revenue ($m), 2007-2008
Table 114: Microbiology Culture, China, Company Share by Revenue ($m), 2007-2008
Table 115: In Vitro Diagnostics, Spain, Overall Revenue ($m), Historic, 2000-2008
Table 116: In Vitro Diagnostics, Spain, Overall Revenue ($m), Forecast, 2008-2015
Table 117: In Vitro Diagnostics, Spain, Cross-Category Analysis, 2000-2015
Table 118: Clinical Chemistry, Spain, Distribution Share by Revenue ($m), 2007-2008
Table 119: Genetic Testing, Spain, Distribution Share by Revenue ($m), 2007-2008
Table 120: Haematology, Spain, Distribution Share by Revenue ($m), 2007-2008
Table 121: Histology and Cytology, Spain, Distribution Share by Revenue ($m), 2007-2008
Table 122: Immuno Chemistry, Spain, Distribution Share by Revenue ($m), 2007-2008
Table 123: Infectious Immunology, Spain, Distribution Share by Revenue ($m), 2007-2008
Table 124: Microbiology Culture, Spain, Distribution Share by Revenue ($m), 2007-2008
Table 125: In Vitro Diagnostics, Spain, Company Share by Revenue ($m), 2008-2008
Table 126: Clinical Chemistry, Spain, Company Share by Revenue ($m), 2007-2008
Table 127: Genetic Testing, Spain, Company Share by Revenue ($m), 2007-2008
Table 128: Haematology, Spain, Company Share by Revenue ($m), 2007-2008
Table 129: Histology And Cytology, Spain, Company Share by Revenue ($m), 2007-2008
Table 130: Immuno Chemistry, Spain, Company Share by Revenue ($m), 2007-2008
Table 131: Infectious Immunology, Spain, Company Share by Revenue ($m), 2007-2008
Table 132: Microbiology Culture, Spain, Company Share by Revenue ($m), 2007-2008
Table 133: In Vitro Diagnostics, UK, Overall Revenue ($m), Historic, 2000-2008
Table 134: In Vitro Diagnostics, UK, Overall Revenue ($m), Forecast, 2008-2015
Table 135: In Vitro Diagnostics, UK, Cross-Category Analysis, 2000-2015
Table 136: Clinical Chemistry, UK, Distribution Share by Revenue ($m), 2007-2008
Table 137: Genetic Testing, UK, Distribution Share by Revenue ($m), 2007-2008
Table 138: Haematology, UK, Distribution Share by Revenue ($m), 2007-2008
Table 139: Histology And Cytology, UK, Distribution Share by Revenue ($m), 2007-2008
Table 140: Immuno Chemistry, UK, Distribution Share by Revenue ($m), 2007-2008
Table 141: Infectious Immunology, UK, Distribution Share by Revenue ($m), 2007-2008
Table 142: Microbiology Culture, UK, Distribution Share by Revenue ($m), 2007-2008
Table 143: In Vitro Diagnostics, UK, Company Share by Revenue ($m), 2008-2008
Table 144: Clinical Chemistry, UK, Company Share by Revenue ($m), 2007-2008
Table 145: Genetic Testing, UK, Company Share by Revenue ($m), 2007-2008
Table 146: Haematology, UK, Company Share by Revenue ($m), 2007-2008
Table 147: Histology and Cytology, UK, Company Share by Revenue ($m), 2007-2008
Table 148: Immuno Chemistry, UK, Company Share by Revenue ($m), 2007-2008
Table 149: Infectious Immunology, UK, Company Share by Revenue ($m), 2007-2008
Table 150: Microbiology Culture, UK, Company Share by Revenue ($m), 2007-2008
Table 151: In Vitro Diagnostics, Brazil, Overall Revenue ($m), Historic, 2000-2008
Table 152: In Vitro Diagnostics, Brazil, Overall Revenue ($m), Forecast, 2008-2015
Table 153: In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2000-2015
Table 154: Clinical Chemistry, Brazil, Distribution Share by Revenue ($m), 2007-2008
Table 155: Genetic Testing, Brazil, Distribution Share by Revenue ($m), 2007-2008
Table 156: Haematology, Brazil, Distribution Share by Revenue ($m), 2007-2008
Table 157: Histology and Cytology, Brazil, Distribution Share by Revenue ($m), 2007-2008
Table 158: Immuno Chemistry, Brazil, Distribution Share by Revenue ($m), 2007-2008
Table 159: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), 2007-2008
Table 160: Microbiology Culture, Brazil, Distribution Share by Revenue ($m), 2007-2008
Table 161: In Vitro Diagnostics, Brazil, Company Share by Revenue ($m), 2008-2008
Table 162: Clinical Chemistry, Brazil, Company Share by Revenue ($m), 2007-2008
Table 163: Genetic Testing, Brazil, Company Share by Revenue ($m), 2007-2008
Table 164: Haematology, Brazil, Company Share by Revenue ($m), 2007-2008
Table 165: Histology and Cytology, Brazil, Company Share by Revenue ($m), 2007-2008
Table 166: Immuno Chemistry, Brazil, Company Share by Revenue ($m), 2007-2008
Table 167: Infectious Immunology, Brazil, Company Share by Revenue ($m), 2007-2008
Table 168: Microbiology Culture, Brazil, Company Share by Revenue ($m), 2007-2008
Table 169: In Vitro Diagnostics, Canada, Overall Revenue ($m), Historic, 2000-2008
Table 170: In Vitro Diagnostics, Canada, Overall Revenue ($m), Forecast, 2008-2015
Table 171: In Vitro Diagnostics, Canada, Cross-Category Analysis, 2000-2015
Table 172: Clinical Chemistry, Canada, Distribution Share by Revenue ($m), 2007-2008
Table 173: Genetic Testing, Canada, Distribution Share by Revenue ($m), 2007-2008
Table 174: Haematology, Canada, Distribution Share by Revenue ($m), 2007-2008
Table 175: Histology And Cytology, Canada, Distribution Share by Revenue ($m), 2007-2008
Table 176: Immuno Chemistry, Canada, Distribution Share by Revenue ($m), 2007-2008
Table 177: Infectious Immunology, Canada, Distribution Share by Revenue ($m), 2007-2008
Table 178: Microbiology Culture, Canada, Distribution Share by Revenue ($m), 2007-2008
Table 179: In Vitro Diagnostics, Canada, Company Share by Revenue ($m), 2008-2008
Table 180: Clinical Chemistry, Canada, Company Share by Revenue ($m), 2007-2008
Table 181: Genetic Testing, Canada, Company Share by Revenue ($m), 2007-2008
Table 182: Haematology, Canada, Company Share by Revenue ($m), 2007-2008
Table 183: Histology and Cytology, Canada, Company Share by Revenue ($m), 2007-2008
Table 184: Immuno Chemistry, Canada, Company Share by Revenue ($m), 2007-2008
Table 185: Infectious Immunology, Canada, Company Share by Revenue ($m), 2007-2008
Table 186: Microbiology Culture, Canada, Company Share by Revenue ($m), 2007-2008
Table 187: In Vitro Diagnostics, India, Overall Revenue ($m), Historic, 2000-2008
Table 188: In Vitro Diagnostics, India, Overall Revenue ($m), Forecast, 2008-2015
Table 189: In Vitro Diagnostics, India, Cross-Category Analysis, 2000-2015
Table 190: Clinical Chemistry, India, Distribution Share by Revenue ($m), 2007-2008
Table 191: Genetic Testing, India, Distribution Share by Revenue ($m), 2007-2008
Table 192: Haematology, India, Distribution Share by Revenue ($m), 2007-2008
Table 193: Histology and Cytology, India, Distribution Share by Revenue ($m), 2007-2008
Table 194: Immuno Chemistry, India, Distribution Share by Revenue ($m), 2007-2008
Table 195: Infectious Immunology, India, Distribution Share by Revenue ($m), 2007-2008
Table 196: Microbiology Culture, India, Distribution Share by Revenue ($m), 2007-2008
Table 197: In Vitro Diagnostics, India, Company Share by Revenue ($m), 2008-2008
Table 198: Clinical Chemistry, India, Company Share by Revenue ($m), 2007-2008
Table 199: Genetic Testing, India, Company Share by Revenue ($m), 2007-2008
Table 200: Haematology, India, Company Share by Revenue ($m), 2007-2008
Table 201: Histology and Cytology, India, Company Share by Revenue ($m), 2007-2008
Table 202: Immuno Chemistry, India, Company Share by Revenue ($m), 2007-2008
Table 203: Infectious Immunology, India, Company Share by Revenue ($m), 2007-2008
Table 204: Microbiology Culture, India, Company Share by Revenue ($m), 2007-2008
Table 205: In Vitro Diagnostics, Australia, Overall Revenue ($m), Historic, 2000-2008
Table 206: In Vitro Diagnostics, Australia, Overall Revenue ($m), Forecast, 2008-2015
Table 207: In Vitro Diagnostics, Australia, Cross-Category Analysis, 2000-2015
Table 208: Clinical Chemistry, Australia, Distribution Share by Revenue ($m), 2007-2008
Table 209: Genetic Testing, Australia, Distribution Share by Revenue ($m), 2007-2008
Table 210: Haematology, Australia, Distribution Share by Revenue ($m), 2007-2008
Table 211: Histology and Cytology, Australia, Distribution Share by Revenue ($m), 2007-2008
Table 212: Immuno Chemistry, Australia, Distribution Share by Revenue ($m), 2007-2008
Table 213: Infectious Immunology, Australia, Distribution Share by Revenue ($m), 2007-2008
Table 214: Microbiology Culture, Australia, Distribution Share by Revenue ($m), 2007-2008
Table 215: In Vitro Diagnostics, Australia, Company Share by Revenue ($m), 2008-2008
Table 216: Clinical Chemistry, Australia, Company Share by Revenue ($m), 2007-2008
Table 217: Genetic Testing, Australia, Company Share by Revenue ($m), 2007-2008
Table 218: Haematology, Australia, Company Share by Revenue ($m), 2007-2008
Table 219: Histology and Cytology, Australia, Company Share by Revenue ($m), 2007-2008
Table 220: Immuno Chemistry, Australia, Company Share by Revenue ($m), 2007-2008
Table 221: Infectious Immunology, Australia, Company Share by Revenue ($m), 2007-2008
Table 222: Microbiology Culture, Australia, Company Share by Revenue ($m), 2007-2008
Table 223: Abbott Laboratories Pipeline Products by Equipment Type
Table 224: Abbott Laboratories Pipeline Products By Development Stage
Table 225: Abbott Laboratories Pipeline Products By Therapy Area
Table 226: Beckman Coulter, Inc. Pipeline Products by Equipment Type
Table 227: Beckman Coulter, Inc. Pipeline Products By Development Stage
Table 228: Beckman Coulter, Inc. Pipeline Products By Therapy Area
Table 229: Beckman Coulter, Inc. Pipeline Products By News Summary
Table 230: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
Table 231: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
Table 232: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
Table 233: ViraCor Laboratories To Merge With IBT Laboratories
Table 234: Bookham Merges With AVANEX To Form Oclaro
Table 235: Sorrento Therapeutics Completes Reverse Acquisition With QuikByte Software
Table 236: Corning Acquires Axygen BioScience And Its Subsidiaries From American Capital
Table 237: PerkinElmer Completes Acquisition Of Sym-Bio LifeScience
Table 238: PerkinElmer Acquires Surendra Genetic Labs
Table 239: Cell Biosciences Enters Into Agreement To Acquire Alpha Innotech
Table 240: Thermo Fisher Scientific To Acquire B.R.A.H.M.S.
Table 241: Danaher To Acquire Remaining 50% Interest In AB SCIEX
Table 242: Danaher To Acquire Analytical Technologies From MDS
Table 243: Dia-B Tech Terminates Acquisition Of Pallane Medical
Table 244: Quest Diagnostics Acquires Caritas Medical Laboratories From Caritas Christi Health Care
Table 245: Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn
Table 246: Laboratory Corporation of America Holdings Completes Acquisition Of Monogram Biosciences
Table 247: Agilent Technologies To Acquire Varian
Table 248: Bostwick To Acquire CBI Services And Fairfax Identity Laboratories From Commonwealth
Table 249: Enigma Diagnostics To Receive Equity Investment From GlaxoSmithKline
Table 250: Caio Auriemo Completes Sale Of Stake In Diagnosticos da America
Table 251: Sonic Healthcare To Acquire 100% Of Lademannbogen Laboratory
Table 252: Adeona Pharmaceuticals Completes Acquisition Of Hartlab
Table 253: ICON Acquires Veeda Laboratories From Veeda Clinical Research
Table 254: Barclays Bank And The Royal Bank of Scotland Receives Approval To Acquire USP Group
Table 255: TOPTICA Photonics Acquires TILL Photonics From Agilent Technologies
Table 256: QIAGEN Enters Into An Agreement With Roche And Idaho Technology
Table 257: AbD Serotec Enters Into Research Collaboration With Foundation for Innovative New Diagnostics
Table 258: Warnex Signs Distribution Agreement With Biron-Laboratoire medical
Table 259: Immunodiagnostic Systems Holdings Enters Into Licensing Agreement With Biosignatures
Table 260: Accumetrics Enters Into Agreement With Grifols
Table 261: Anteo Diagnostics Enters Into An Agreement With DioSion Diagnostics
Table 262: IRIS International Enters Into Exclusive Distribution Agreement With Fujirebio
Table 263: Rosetta Genomics Enters Into Distribution Agreement With Super Religare Laboratories
Table 264: Epigenomics Signs Licensing Agreement With ARUP Laboratories
Table 265: Horizon Discovery Enters Into An Agreement With Newcastle University
Table 266: Warnex Signs Distribution Agreement With Rosetta Genomics
Table 267: Lab21 Enters Into Distribution Agreement With AdnaGen
Table 268: Celera Enters Into Agreement With Aurora Health Care
Table 269: The Addario Lung Cancer Medical Institute Enters Into An Agreement With Response Genetics
Table 270: QuantRx Biomedical Enters Into Joint Venture Agreement With NuRx Pharmaceuticals
Table 271: DxS Signs Cross-Licensing Agreement With Epigenomics
Table 272: Enigma Diagnostics Enters Into An Agreement With Roche Molecular Systems
Table 273: IVAX Diagnostics Amends Its Distribution Agreement With IMMCO Diagnostics
Table 274: IVAX Diagnostics Signs Distribution Agreement With Augurix
Table 275: Prodesse Enters Into A licensing Agreement With Abbott Laboratories
Table 276: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures
Figure 1: In Vitro Diagnostics, Global, Overall Revenue ($m), Historic, 2000-2008
Figure 2: In Vitro Diagnostics, Global, Overall Revenue ($m), Forecast, 2008-2015
Figure 3: In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015
Figure 4: In Vitro Diagnostics, Global, Company share (%), 2008
Figure 5: In Vitro Diagnostics, Market Attractiveness Analysis, By Category, 2008 - 2015
Figure 6: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2000-2015
Figure 7: In Vitro Diagnostics, US, Overall Revenue ($m), Historic, 2000-2008
Figure 8: In Vitro Diagnostics, US, Overall Revenue ($m), Forecast, 2008-2015
Figure 9: In Vitro Diagnostics, US, Cross-Category Analysis, 2000-2015
Figure 10: In Vitro Diagnostics, US, Company Share (%), 2008
Figure 11: Clinical Chemistry, US, Company Share (%), 2008
Figure 12: Genetic Testing, US, Company Share (%), 2008
Figure 13: Haematology, US, Company Share (%), 2008
Figure 14: Histology And Cytolo
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Histology & Cytology Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!